Dysbiosis News and Research

RSS

Dysbiosis is a condition caused by an imbalance in the bacterial community (microbiome) of the human gut. Dysbiosis disrupts the ecoystsem of the gut, resulting in symptoms such as diarrhea, constipation, bloating, and indigestion, among others.

Unfolded protein response disruptions contribute to colorectal cancer and gut-related disorders

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and communication between the gut microbiota and the nervous system.

20 Feb 2025

CPRIT awards nearly $23 million to MD Anderson for cancer research projects

The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to advance new breakthroughs in discovery, translational, clinical and prevention science.

20 Feb 2025

Do prenatal antibiotics weaken breast milk immunity? A new study aims to find out

A new study will investigate whether prenatal antibiotic use impairs breast milk immune function and disrupts neonatal gut microbiota, potentially affecting infant health. Researchers aim to assess how prolonged antibiotic exposure in late pregnancy alters breast milk IgA and neonatal immune development.

19 Feb 2025

Can the carnivore diet trigger kidney stones? Case study raises red flags

A case study in The American Journal of Clinical Nutrition examines how one patient’s switch to a carnivore diet increased kidney stone risk by raising calcium, uric acid, and oxalate levels while reducing protective citrate.

19 Feb 2025

Alzheimer’s disease may leave early signs in the gut, study finds

Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's disease models, suggesting a potential early biomarker.

3 Feb 2025

X-ray tomography reveals the gut-brain connection in Alzheimer's

Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in Grenoble, France, have discovered how X-ray micro- and nano- tomography can provide clues on the processes that link the gut neurons with those in the brain and may trigger Alzheimer's.

31 Jan 2025

Researchers propose personalized probiotic therapies for inflammatory diseases

A new approach to treating inflammatory diseases through personalized probiotic therapies – also known as precision medicine – has been proposed by researchers at the University of Surrey.

29 Jan 2025

How gut microbiota impacts childhood obesity

Gut microbiota plays a critical role in childhood obesity by influencing energy metabolism, inflammation, and appetite regulation, with emerging therapeutic strategies like probiotics, dietary interventions, and fecal microbiota transplantation showing promise.

21 Jan 2025

Gut microbes and plant foods: a powerful duo for healthy aging

Gut microbiota and phytochemicals synergize to produce bioactive metabolites that combat aging, reduce inflammation, and enhance healthspan by supporting gut and systemic health.

20 Jan 2025

New study links cervicovaginal microbiome to increased risk of Chlamydia infections

The cervicovaginal microbiome's role in Chlamydia infections underscores the need for molecular classification to enhance prevention and treatment strategies.

17 Jan 2025

Unveiling the metabolic pathways of Fusobacterium nucleatum in OSCC

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.

17 Jan 2025

Hormonal shifts in menopause redefine women’s microbiome and risks

Research explores how menopause-induced hormonal shifts affect the microbiome, influencing oral, gut, and urogenital health, and highlights the potential of personalized interventions to enhance well-being.

15 Jan 2025

Study unravels the links between obesity and cancer

Obesity, recognized as a complex and growing health issue, is associated with an increased risk of various cancers. A comprehensive review provides insights into the mechanisms linking obesity to cancer risk and discusses potential clinical implications.

15 Jan 2025

Understanding the mechanisms behind alcohol-associated liver disease

A newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this condition.

19 Dec 2024

Can probiotics restore antibiotic-perturbed microbiota?

Probiotics can reduce antibiotic-associated diarrhea but don't fully restore gut microbiota. Further studies are essential to evaluate their long-term effects.

19 Dec 2024

The role of phytochemicals in combating metabolic diseases

This editorial reviews the impact of phytochemicals on metabolic diseases, emphasizing their potential in reducing inflammation and improving health outcomes.

19 Dec 2024

International experts set framework for microbiota diagnostics

The gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide treatment, but at present there is a lack of solid scientific evidence to support these claims.

6 Dec 2024

How carrageenan affects insulin resistance

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin resistance in overweight individuals, mediated by gut permeability and inflammation. Effects were linked to BMI but not observed in non-overweight participants during short-term exposure.

3 Dec 2024

Parkinson's disease drug disrupts the gut microbiome by inducing iron deficiency

In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration with the University of Southampton, Aalborg University and Boston University, have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency.

22 Nov 2024

Green tea kombucha could transform your gut and boost your weight-loss journey

Green tea kombucha improves gastrointestinal symptoms and alters the serum metabolome in individuals with excess body weight on an energy-restricted diet, showing potential metabolic health benefits.

18 Nov 2024